Oncologist-approved cancer information from the American Society of Clinical Oncology
Printer Friendly
Download PDF

Lymphoma - Hodgkin

This section has been reviewed and approved by the Cancer.Net Editorial Board, 5/2013
Treatment Options


ON THIS PAGE: You will learn about the different ways doctors use to treat people with this type of cancer. To see other pages, use the menu on the side of your screen.

This section outlines treatments that are the standard of care (the best proven treatments available) for this specific type of cancer. When making treatment plan decisions, patients are also encouraged to consider clinical trials as an option. A clinical trial is a research study to test a new treatment to evaluate whether it is safe, effective, and possibly better than the standard treatment. Your doctor can help you review all treatment options. For more information, see the Clinical Trials and Latest Research sections.

Treatment overview

In cancer care, different types of doctors often work together to create a patient’s overall treatment plan that combines different types of treatments. This is called a multidisciplinary team.

The original treatments for Hodgkin lymphoma, developed in the 1960s and 1970s, were very effective. However, long-term follow-up care of people who received these treatments has shown that they are at risk for side effects later in life, including infertility (the inability to have children), heart problems (such as heart failure, leaky heart valves, and heart attacks), and secondary cancers, such as lung cancer and breast cancer (in women). These long-term problems were partly caused by the types of chemotherapy used at that time and partly caused by the use of high doses of radiation therapy delivered to large areas of the body. Learn more about the late effects of treatment for Hodgkin lymphoma.

To avoid or reduce the risk of these problems, today’s treatments for Hodgkin lymphoma involve newer types and doses of chemotherapy and the use of radiation therapy directed at smaller areas of the body. Most patients with classical Hodgkin lymphoma, even stage I or stage II, often receive some chemotherapy, followed by radiation therapy to the affected lymph node areas. For some patients with early-stage disease, it may be possible to have treatment with only a relatively short course of chemotherapy, with or without radiation therapy. This applies to only a few patients and should be discussed with your doctor. For stage III or stage IV disease, chemotherapy is still the primary treatment, although additional radiation therapy may be recommended, especially to areas of large lymph nodes.

People with lymphoma may have concerns about if or how their treatment may affect their sexual function and fertility (ability to have children). These topics should be discussed with the health care team before treatment begins.

Descriptions of the most common treatment options for Hodgkin lymphoma are listed below. Treatment options and recommendations depend on several factors, including the type and stage of cancer, possible side effects, and the patient’s preferences and overall health. Take time to learn about your treatment options and be sure to ask questions about things that are unclear. Also, talk about the goals of each treatment with your doctor and what you can expect while receiving the treatment. Learn more about making treatment decisions.


Chemotherapy is the use of drugs to kill cancer cells, usually by stopping the cancer cells’ ability to grow and divide. Systemic chemotherapy is delivered through the bloodstream to reach cancer cells throughout the body. Chemotherapy is given by a medical oncologist, a doctor who specializes in treating cancer with medication, or a hematologist, a doctor who specializes in treating blood disorders. A chemotherapy regimen usually consists of a specific number of cycles given over a set period of time. A patient may receive one drug at a time or combinations of different drugs at the same time.

Many different types of chemotherapy may be used for Hodgkin lymphoma. The most commonly used combination of drugs in the United States is called ABVD. Another combination of drugs, known as BEACOPP, is now widely used in Europe and is being used more often in the United States. The drugs that make up these combinations of chemotherapy are listed below:

  • ABVD: Doxorubicin (Adriamycin), bleomycin (Blenoxane), vinblastine (Velban, Velsar), and dacarbazine (DTIC-Dome). ABVD chemotherapy is usually given every two weeks for two to eight months.
  • BEACOPP: Bleomycin, etoposide (Toposar, VePesid), doxorubicin, cyclophosphamide (Cytoxan, Neosar), vincristine (Vincasar PFS, Oncovin), procarbazine (Matulane), and prednisone (multiple brand names). There are several different treatment schedules, but different drugs are usually given every two weeks.

If Hodgkin lymphoma comes back after initial (first-line) treatment with ABVD or BEACOPP, there are several second-line treatments. Many of these treatments are given in preparation for an autologous stem cell transplant (see below), but they can also be given to control the disease and its symptoms.

  • ICE: Ifosfamide (Ifex), carboplatin (Paraplatin), etoposide. ICE is usually given every two or three weeks for two to three months.
  • ESHAP or DHAP: Etoposide, methylprenisolone sodium succinate (Solu-Medrol), high dose cytarabine (Cytosar-U), cisplatin (Platinol); OR dexamethasone (multiple brand names), high dose cytarabine, cisplatin. ESHAP or DHAP regimens are given every three weeks for two to three months.
  • GVD, Gem-Ox, or GDP: Gemcitabine (Gemzar), vinorelbine (Navelbine), doxorubicin; OR gemcitabine, oxaliplatin (Eloxatin); OR gemcitabine, dexamethasone, cisplatin. Gemcitabine-based regimens are either given two weeks in a row followed by an off-week or every other week.
  • Brentuximab vedotin (Adcetris): Brentuximab vedotin is an antibody-drug conjugate, which means it delivers chemotherapy only to cells that have a special protein on the surface called CD30. Brentuximab vedotin is usually given every three weeks for up to sixteen cycles, although sometimes it is given every four weeks.

It is unclear which of these chemotherapy treatments is best for patients with Hodgkin lymphoma, and the best treatment may differ depending on the type and stage of the lymphoma. For this reason, many clinical trials are underway comparing these different chemotherapy treatments. These clinical trials are designed to find out which combination works best with the fewest short-term and long-term side effects.

During chemotherapy, your doctors will usually repeat some of the original tests, especially CT scans and PET scans. These tests are used to monitor the lymphoma and see how well treatment is working.

The side effects of chemotherapy depend on the individual and the dose used, but they can include fatigue, risk of infection, nausea and vomiting, hair loss, loss of appetite, and diarrhea. These side effects usually go away once treatment is finished. Although the risk of long-term side effects has decreased as treatments have improved, chemotherapy still can cause long-term side effects. Learn more about late effects of treatment.

Learn more about chemotherapy and preparing for treatment. The medications used to treat cancer are continually being evaluated. Talking with your doctor is often the best way to learn about the medications prescribed for you, their purpose, and their potential side effects or interactions with other medications. Learn more about your prescriptions by using searchable drug databases.

Radiation therapy

Radiation therapy is the use of high energy x-rays or other particles to kill cancer cells. A doctor who specializes in giving radiation therapy to treat cancer is called a radiation oncologist. Radiation therapy for Hodgkin lymphoma is always external-beam radiation therapy, which is radiation given from a machine outside the body. A radiation therapy regimen (schedule) usually consists of a specific number of treatments given over a set period of time.

Whenever possible, radiation therapy is now directed only at the affected lymph node areas to reduce the risk of damaging healthy surrounding tissues. Some newer radiation therapy techniques that may be used for some patients include involved-node radiotherapy (focuses the radiation on the lymph nodes that contain cancer), intensity modulated radiotherapy (IMRT; varies the strength of the radiation beams so less healthy tissue is affected), and proton therapy (uses protons rather than x-rays to treat the cancer).

Immediate side effects from radiation therapy depend on the area of the body that is being treated. These may include fatigue, mild skin reactions, upset stomach, and loose bowel movements. Patients who receive radiation to the neck may have a sore mouth and/or throat. Most side effects go away soon after treatment is finished.

Although the risk for long-term side effects reduces as treatments improve, radiation therapy may still sometimes cause long-term side effects, also called late effects. To lessen the risk of long-term side effects, clinical trials are being done to determine the best doses and smallest possible area to direct the radiation therapy.

Learn more about radiation therapy.

Stem cell transplantation/bone marrow transplantation

A stem cell transplant is a medical procedure in which a patient’s bone marrow is replaced by highly specialized cells, called hematopoietic stem cells, that develop into healthy bone marrow. Hematopoietic stem cells are found both in the bloodstream and in the bone marrow. Today, this procedure is more commonly called a stem cell transplant, rather than bone marrow transplant, because it is stem cells in the blood that are typically being transplanted, not the actual bone marrow tissue.

Before recommending transplantation, doctors will talk with the patient about the risks of this treatment and consider several other factors, such as the results of any previous treatment and the patient’s age and general health. It is very important to talk with a doctor at an experienced transplant center about the risks and benefits of stem cell transplantation. Stem cell transplantation is not used as a first treatment for Hodgkin lymphoma, but it may be recommended for patients who have lymphoma remaining in the bone marrow after treatment or for those who have a recurrence.

There are two types of stem cell transplantation depending on the source of the replacement blood stem cells: autologous (AUTO) and allogeneic (ALLO).

In an AUTO transplant, the patient’s own stem cells are used. The stem cells are obtained from the patient when he or she is in remission from previous treatment. The stem cells are then frozen until they are needed, usually after the high-dose treatment (explained below) is completed.

In an ALLO transplant, stem cells are obtained from a donor whose tissue matches the patient’s on a genetic level; this testing is called HLA-typing. Most often, a patient’s brother or sister serves as the donor, although an unrelated person can serve as a donor as well.

In both types, the goal of transplantation is to destroy cancer cells in the marrow, blood, and other parts of the body and allow replacement blood stem cells to create healthy bone marrow. In most stem cell transplants, the patient is treated with high doses of chemotherapy and/or radiation therapy to destroy as many cancer cells as possible. This also destroys the patient’s bone marrow tissue and suppresses the patient’s immune system so that, in an ALLO transplant, the donor cells are not rejected by the body.

It is important to discuss the potential risks and benefits of both these types of transplants with the doctor in order to determine the best choice for an individual patient.

Learn more about bone marrow and stem cell transplantation.

Getting care for symptoms and side effects

Lymphoma and its treatment often cause side effects. In addition to treatment to slow, stop, or eliminate the disease, an important part of care is relieving a person’s symptoms and side effects. This approach is called palliative or supportive care, and it includes supporting the patient with his or her physical, emotional, and social needs.

Palliative care can help a person at any stage of illness. People often receive treatment for the lymphoma and treatment to ease side effects at the same time. In fact, patients who receive both often have less severe symptoms, better quality of life, and report they are more satisfied with treatment.

Palliative treatments vary widely and often include medication, nutritional changes, relaxation techniques, and other therapies. You may also receive palliative treatments similar to those meant to eliminate the cancer, such as chemotherapy, surgery, and radiation therapy. Talk with your doctor about the goals of each treatment in your treatment plan.

Before treatment begins, talk with your health care team about the possible side effects of your specific treatment plan and supportive care options. And during and after treatment, be sure to tell your doctor or another health care team member if you are experiencing a problem so it is addressed as quickly as possible.

Learn more about palliative care.

Recurrent Hodgkin lymphoma

A remission is when lymphoma cannot be detected in the body and there are no symptoms. This may also be called “no evidence of disease” or NED. 

A remission can be temporary or permanent. This uncertainty leads to many survivors feeling worried or anxious that the disease will come back. While many remissions are permanent, it’s important to talk with your doctor about the possibility of the disease returning. Understanding the risk of recurrence and the treatment options may help you feel more prepared if the lymphoma does return. Learn more about coping with the fear of recurrence.   

If the cancer does return after the original treatment, it is called recurrent cancer. It may come back in the same place (called a local recurrence), nearby (regional recurrence), or in another place (distant recurrence). Recurrent cancer is uncommon for people with Hodgkin lymphoma.

If it does recur, a cycle of testing will begin again to learn as much as possible about the recurrence, including whether the cancer’s stage has changed. After testing is done, you and your doctor will talk about your treatment options. Most often, the first step is to give a "second-line" chemotherapy treatment, such as ICE, ESHAP, DHAP, or gemcitabine-based treatments (see Chemotherapy above). The purpose of this chemotherapy is to reduce the amount of Hodgkin lymphoma as much as possible before a stem cell transplant so that the transplant has the best possible chance of curing the disease. The drug brentuximab vedotin has been recently approved by the FDA for patients with recurrent Hodgkin lymphoma, and it may also be a treatment option. Your doctor may also suggest clinical trials that are studying new ways to treat this type of recurrent cancer.

People with recurrent cancer often experience emotions such as disbelief or fear. Patients are encouraged to talk with their health care team about these feelings and ask about support services to help them cope.

Learn more about dealing with cancer recurrence.

Progressive Hodgkin lymphoma

Progressive disease is when the cancer becomes larger or spreads while the patient is being treated for the original lymphoma. However, progressive disease is uncommon for people with Hodgkin lymphoma.

Patients with this diagnosis are encouraged to talk with doctors who are experienced in treating this stage of cancer, because there can be different opinions about the best treatment plan. Learn more about seeking a second opinion before starting treatment, so you are comfortable with the treatment plan chosen. This discussion may include clinical trials.

Most patients will be advised to receive a stem cell transplantation (see above), which appears to be more effective at treating progressive Hodgkin lymphoma than standard chemotherapy. Supportive care will also be important to help relieve symptoms and side effects.

For most patients, a diagnosis of progressive lymphoma is very stressful and, at times, difficult to bear. Patients and their families are encouraged to talk about the way they are feeling with doctors, nurses, social workers, or other members of the health care team. It may also be helpful to talk with other patients, including through a support group.

If treatment fails

Recovery from lymphoma is not always possible. If treatment is not successful, the disease may be called advanced or terminal disease.

This diagnosis is stressful, and this is difficult to discuss for many people. However, it is important to have open and honest conversations with your doctor and health care team to express your feelings, preferences, and concerns. The health care team is there to help, and many team members have special skills, experience, and knowledge to support patients and their families. Making sure a person is physically comfortable and free from pain is extremely important.

Patients who have advanced cancer and who are expected to live less than six months may want to consider a type of palliative care called hospice care. Hospice care is designed to provide the best possible quality of life for people who are near the end of life. You and your family are encouraged to think about where you would be most comfortable: at home, in the hospital, or in a hospice environment. Nursing care and special equipment can make staying at home a workable alternative for many families. Learn more about advanced care planning.

After the death of a loved one, many people need support to help them cope with the loss. Learn more about grief and bereavement.

The next section helps explain clinical trials, which are research studies. Use the menu on the side of your screen to select About Clinical Trials, or you can select another section, to continue reading this guide.  

© 2005-2014 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.

Connect With Us: